Global GM1 Gangliosidosis Treatment Market Growth (Status and Outlook) 2022-2028
- LP 4886470
- 60 Pages
- March 2022
- Pharmaceuticals
The United States GM1 Gangliosidosis Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global GM1 Gangliosidosis Treatment market, reaching US$ million by the year 2028. As for the Europe GM1 Gangliosidosis Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main GM1 Gangliosidosis Treatment players cover Axovant Gene Therapies Ltd, Passage Bio and Lysogene, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of GM1 Gangliosidosis Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
LYS-GM101
PBGM01
AXO-AAV-GM1
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Type 1 GM1 Gangliosidosis
Type 2 GM1 Gangliosidosis
Type 3 GM1 Gangliosidosis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Axovant Gene Therapies Ltd
Passage Bio and Lysogene
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global GM1 Gangliosidosis Treatment Market Size 2017-2028
2.1.2 GM1 Gangliosidosis Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 GM1 Gangliosidosis Treatment Segment by Type
2.2.1 LYS-GM101
2.2.2 PBGM01
2.2.3 AXO-AAV-GM1
2.3 GM1 Gangliosidosis Treatment Market Size by Type
2.3.1 GM1 Gangliosidosis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global GM1 Gangliosidosis Treatment Market Size Market Share by Type (2017-2022)
2.4 GM1 Gangliosidosis Treatment Segment by Application
2.4.1 Type 1 GM1 Gangliosidosis
2.4.2 Type 2 GM1 Gangliosidosis
2.4.3 Type 3 GM1 Gangliosidosis
2.5 GM1 Gangliosidosis Treatment Market Size by Application
2.5.1 GM1 Gangliosidosis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global GM1 Gangliosidosis Treatment Market Size Market Share by Application (2017-2022)
3 GM1 Gangliosidosis Treatment Market Size by Player
3.1 GM1 Gangliosidosis Treatment Market Size Market Share by Players
3.1.1 Global GM1 Gangliosidosis Treatment Revenue by Players (2020-2022)
3.1.2 Global GM1 Gangliosidosis Treatment Revenue Market Share by Players (2020-2022)
3.2 Global GM1 Gangliosidosis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GM1 Gangliosidosis Treatment by Regions
4.1 GM1 Gangliosidosis Treatment Market Size by Regions (2017-2022)
4.2 Americas GM1 Gangliosidosis Treatment Market Size Growth (2017-2022)
4.3 APAC GM1 Gangliosidosis Treatment Market Size Growth (2017-2022)
4.4 Europe GM1 Gangliosidosis Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa GM1 Gangliosidosis Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas GM1 Gangliosidosis Treatment Market Size by Country (2017-2022)
5.2 Americas GM1 Gangliosidosis Treatment Market Size by Type (2017-2022)
5.3 Americas GM1 Gangliosidosis Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GM1 Gangliosidosis Treatment Market Size by Region (2017-2022)
6.2 APAC GM1 Gangliosidosis Treatment Market Size by Type (2017-2022)
6.3 APAC GM1 Gangliosidosis Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe GM1 Gangliosidosis Treatment by Country (2017-2022)
7.2 Europe GM1 Gangliosidosis Treatment Market Size by Type (2017-2022)
7.3 Europe GM1 Gangliosidosis Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa GM1 Gangliosidosis Treatment by Region (2017-2022)
8.2 Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global GM1 Gangliosidosis Treatment Market Forecast
10.1 Global GM1 Gangliosidosis Treatment Forecast by Regions (2023-2028)
10.1.1 Global GM1 Gangliosidosis Treatment Forecast by Regions (2023-2028)
10.1.2 Americas GM1 Gangliosidosis Treatment Forecast
10.1.3 APAC GM1 Gangliosidosis Treatment Forecast
10.1.4 Europe GM1 Gangliosidosis Treatment Forecast
10.1.5 Middle East & Africa GM1 Gangliosidosis Treatment Forecast
10.2 Americas GM1 Gangliosidosis Treatment Forecast by Country (2023-2028)
10.2.1 United States GM1 Gangliosidosis Treatment Market Forecast
10.2.2 Canada GM1 Gangliosidosis Treatment Market Forecast
10.2.3 Mexico GM1 Gangliosidosis Treatment Market Forecast
10.2.4 Brazil GM1 Gangliosidosis Treatment Market Forecast
10.3 APAC GM1 Gangliosidosis Treatment Forecast by Region (2023-2028)
10.3.1 China GM1 Gangliosidosis Treatment Market Forecast
10.3.2 Japan GM1 Gangliosidosis Treatment Market Forecast
10.3.3 Korea GM1 Gangliosidosis Treatment Market Forecast
10.3.4 Southeast Asia GM1 Gangliosidosis Treatment Market Forecast
10.3.5 India GM1 Gangliosidosis Treatment Market Forecast
10.3.6 Australia GM1 Gangliosidosis Treatment Market Forecast
10.4 Europe GM1 Gangliosidosis Treatment Forecast by Country (2023-2028)
10.4.1 Germany GM1 Gangliosidosis Treatment Market Forecast
10.4.2 France GM1 Gangliosidosis Treatment Market Forecast
10.4.3 UK GM1 Gangliosidosis Treatment Market Forecast
10.4.4 Italy GM1 Gangliosidosis Treatment Market Forecast
10.4.5 Russia GM1 Gangliosidosis Treatment Market Forecast
10.5 Middle East & Africa GM1 Gangliosidosis Treatment Forecast by Region (2023-2028)
10.5.1 Egypt GM1 Gangliosidosis Treatment Market Forecast
10.5.2 South Africa GM1 Gangliosidosis Treatment Market Forecast
10.5.3 Israel GM1 Gangliosidosis Treatment Market Forecast
10.5.4 Turkey GM1 Gangliosidosis Treatment Market Forecast
10.5.5 GCC Countries GM1 Gangliosidosis Treatment Market Forecast
10.6 Global GM1 Gangliosidosis Treatment Forecast by Type (2023-2028)
10.7 Global GM1 Gangliosidosis Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Axovant Gene Therapies Ltd
11.1.1 Axovant Gene Therapies Ltd Company Information
11.1.2 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product Offered
11.1.3 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Axovant Gene Therapies Ltd Main Business Overview
11.1.5 Axovant Gene Therapies Ltd Latest Developments
11.2 Passage Bio and Lysogene
11.2.1 Passage Bio and Lysogene Company Information
11.2.2 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product Offered
11.2.3 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Passage Bio and Lysogene Main Business Overview
11.2.5 Passage Bio and Lysogene Latest Developments
12 Research Findings and Conclusion
Table 1. GM1 Gangliosidosis Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of LYS-GM101
Table 3. Major Players of PBGM01
Table 4. Major Players of AXO-AAV-GM1
Table 5. GM1 Gangliosidosis Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global GM1 Gangliosidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global GM1 Gangliosidosis Treatment Market Size Market Share by Type (2017-2022)
Table 8. GM1 Gangliosidosis Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global GM1 Gangliosidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global GM1 Gangliosidosis Treatment Market Size Market Share by Application (2017-2022)
Table 11. Global GM1 Gangliosidosis Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global GM1 Gangliosidosis Treatment Revenue Market Share by Player (2020-2022)
Table 13. GM1 Gangliosidosis Treatment Key Players Head office and Products Offered
Table 14. GM1 Gangliosidosis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global GM1 Gangliosidosis Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global GM1 Gangliosidosis Treatment Market Size Market Share by Regions (2017-2022)
Table 19. Americas GM1 Gangliosidosis Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas GM1 Gangliosidosis Treatment Market Size Market Share by Country (2017-2022)
Table 21. Americas GM1 Gangliosidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas GM1 Gangliosidosis Treatment Market Size Market Share by Type (2017-2022)
Table 23. Americas GM1 Gangliosidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas GM1 Gangliosidosis Treatment Market Size Market Share by Application (2017-2022)
Table 25. APAC GM1 Gangliosidosis Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Region (2017-2022)
Table 27. APAC GM1 Gangliosidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Type (2017-2022)
Table 29. APAC GM1 Gangliosidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Application (2017-2022)
Table 31. Europe GM1 Gangliosidosis Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Country (2017-2022)
Table 33. Europe GM1 Gangliosidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Type (2017-2022)
Table 35. Europe GM1 Gangliosidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of GM1 Gangliosidosis Treatment
Table 44. Key Market Challenges & Risks of GM1 Gangliosidosis Treatment
Table 45. Key Industry Trends of GM1 Gangliosidosis Treatment
Table 46. Global GM1 Gangliosidosis Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global GM1 Gangliosidosis Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global GM1 Gangliosidosis Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global GM1 Gangliosidosis Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global GM1 Gangliosidosis Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global GM1 Gangliosidosis Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 52. Axovant Gene Therapies Ltd Details, Company Type, GM1 Gangliosidosis Treatment Area Served and Its Competitors
Table 53. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product Offered
Table 54. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Axovant Gene Therapies Ltd Main Business
Table 56. Axovant Gene Therapies Ltd Latest Developments
Table 57. Passage Bio and Lysogene Details, Company Type, GM1 Gangliosidosis Treatment Area Served and Its Competitors
Table 58. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product Offered
Table 59. Passage Bio and Lysogene Main Business
Table 60. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Passage Bio and Lysogene Latest Developments
List of Figures
Figure 1. GM1 Gangliosidosis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global GM1 Gangliosidosis Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global GM1 Gangliosidosis Treatment Market Size Market Share by Type in 2021
Figure 7. GM1 Gangliosidosis Treatment in Type 1 GM1 Gangliosidosis
Figure 8. Global GM1 Gangliosidosis Treatment Market: Type 1 GM1 Gangliosidosis (2017-2022) & ($ Millions)
Figure 9. GM1 Gangliosidosis Treatment in Type 2 GM1 Gangliosidosis
Figure 10. Global GM1 Gangliosidosis Treatment Market: Type 2 GM1 Gangliosidosis (2017-2022) & ($ Millions)
Figure 11. GM1 Gangliosidosis Treatment in Type 3 GM1 Gangliosidosis
Figure 12. Global GM1 Gangliosidosis Treatment Market: Type 3 GM1 Gangliosidosis (2017-2022) & ($ Millions)
Figure 13. Global GM1 Gangliosidosis Treatment Market Size Market Share by Application in 2021
Figure 14. Global GM1 Gangliosidosis Treatment Revenue Market Share by Player in 2021
Figure 15. Global GM1 Gangliosidosis Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas GM1 Gangliosidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC GM1 Gangliosidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe GM1 Gangliosidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa GM1 Gangliosidosis Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas GM1 Gangliosidosis Treatment Value Market Share by Country in 2021
Figure 21. Americas GM1 Gangliosidosis Treatment Consumption Market Share by Type in 2021
Figure 22. Americas GM1 Gangliosidosis Treatment Market Size Market Share by Application in 2021
Figure 23. United States GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Region in 2021
Figure 28. APAC GM1 Gangliosidosis Treatment Market Size Market Share by Application in 2021
Figure 29. China GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Country in 2021
Figure 36. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Type in 2021
Figure 37. Europe GM1 Gangliosidosis Treatment Market Size Market Share by Application in 2021
Figure 38. Germany GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country GM1 Gangliosidosis Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries GM1 Gangliosidosis Treatment Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
